Feru-guard for Behavioral Symptoms in Dementia
Behavioral and Psychiatric Symptoms of Dementia
About this trial
This is an interventional treatment trial for Behavioral and Psychiatric Symptoms of Dementia
Eligibility Criteria
Inclusion Criteria:
- 55 years old or older.
- Diagnosis of AD, vascular, and mixed dementia
- Neuropsychiatric Inventory Questionnaire (NPI-Q) at least 3 items out of 12 items are rated as "present."
- Use of cholinesterase inhibitors, antidepressants and or antipsychotics medications is allowed, if on stable dosage for at least 2 months.
- Use of memantine and/or serotonin reuptake inhibitors is also allowed, if on stable dose for at least 2 months.
- Have a committed caregiver who is able and willing to assist them with medications, provide study participant information, and attend all study visits.
- Sufficient English language skills to complete all testing.
- MMSE score of 25 or lower.
Exclusion Criteria:
- Participants who started using antipsychotics or anticholinergics within the previous 2 months.
- Participants on blood thinners such as warfarin (Coumadin, jantoven), rivaroxaban (xarelto), fondaparinux (arixtra), dibigatran (pradaxa), apixaban (eliquis) dalteparin (fragmin), enoxaparin (lovenox). Aspirin use is allowed.
- Participants without an identified caregiver.
- Participants with delirium caused by medicinal poisoning or drug intoxication.
Participants who have had the following diseases before the onset of cognitive impairment:
- Alcoholism
- Manic depression or bipolar disorder
- Schizophrenia
- Participants with malignancy or an acute inflammatory disease.
- Participants with critical circulatory, respiratory, kidney, or liver disease or diabetes.
- BMI of >30.
- Participants who have taken Feru-guard, ferulic acid, or Angelica archangelica supplementation within the last year.
- Enrollment in another clinical trial or treatment study within the previous 6 months.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Feru-guard
Placebo
Over a 12 week period participants will take two 280 mg hard gel capsules of Feru-guard 100M per day (1 capsule am, 1 capsule pm). One capsule will be taken in the morning with a meal and one capsule will be taken in the afternoon with a meal. Each capsule contains 180.32 mg ferulic acid and 20.02 mg of Angelica archangelica. Total daily dose will be 560mg of Feru-guard 100M, with 360.64 mg of ferulic acid and 40.04 mg of Angelica archangelica.
Over a 12 week period participants will take two 280 mg hard gel capsules of a placebo per day (1 capsule am, 1 capsule pm). One capsule will be taken in the morning with a meal and one capsule will be taken in the afternoon with a meal.Total daily dosage will be 560mg of a maltodextrin, calcium stearate, and vanilla food flavor mixture.